Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT04427618

Completed

Tranexamic Acid in the Prevention of Postpartum Hemorrhage in Elective Caesarean Section

Postpartum Hemorrhage | Tranexamic Acid
NCT00969397

Withdrawn

Combined Use of Pulsed Dye Laser and Topical Antiangiogenic Agents for Treatment of Port Wine Stain Birthmarks

Port Wine Stain
NCT01692158

Completed

Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Subcutaneous Single Dose

Healthy
NCT05598086

Completed

Anti-fibrinolytic and Anti-inflammatory Effects of Local Infiltration of Tranexamic Acid in Patients With Calcaneal Fractures

Fibrinolysis | Fracture | Tranexamic Acid | Inflammatory
NCT05281549

Active, not recruiting

Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-II）

Acute Ischemic Stroke
NCT03022292

Completed

The IAI-OCTA Study; a Study of OCT-Angiography Analysis Efficacy (IAI-OCTA)

Wet Macular Degeneration
NCT01331616

Withdrawn

Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab

Glioblastoma | Optic Neuropathy
NCT03541668

Completed

Study of rhPro-UK in Patients With Acute Ischaemic Stroke in 4.5 Hours After Stroke Onset(PROST)

Acute Ischaemic Stroke
NCT02103738

Completed

Canadian Treat and Extend Analysis Trial With Ranibizumab (CAN-TREAT)

wetAMD
NCT02278263

Completed

Tranexamic Acid in Knee Joint Surgery (TRACKS)

Osteoarthritis
NCT04377295

Completed

Evaluation of Retinal and Vascular Features in Radiation Maculopathy After Intravitreal Injections of Ranibizumab

Radiation Maculopathy
NCT01260506

Completed

Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme

Glioblastoma Multiforme
NCT02151695

Completed

Safety and Efficacy of Aflibercept in Proliferative Diabetic Retinopathy.

Naive Patients With Uncomplicated Proliferative Diabetic Retinopathy
NCT00717756

Completed

Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial

Liver Cancer
NCT03913806

Completed

FLuoresence Image Guided Surgery With A VEGF-targeted Tracer in Soft-tissue Sarcomas in Humans Approach With Bevacizumab-IRDye 800CW (FLASH)

Soft Tissue Sarcoma
NCT04213170

Unknown

Sintilimab Combined With Bevacizumab for Brain Metastases From Non-small Cell Lung Cancer

Non Small Cell Lung Cancer | Bevacizumab | Brain Metastases | Sintilimab
NCT01752075

Completed

A Non-interventional, Observational Post-marketing Registry of Patients Treated With Revlimid (Lenalidomide) in Taiwan

Multiple Myeloma
NCT01347944

Completed

MORE - Monitoring Revlimid - Collecting of Patient Information From Myelodysplastic Syndrome (MDS) Italian National Registry (MORE)

Myelodysplastic Syndrome
NCT00044382

Completed

Study of the Safety and Efficacy of CC-5013 Treatment For Patients With Myelodysplastic Syndrome

Myelodysplastic Syndrome
NCT04087746

Completed

Comparison of Aflibercept Versus Ranibizumab in Management of Diabetic Macular Edema (DME) (DME)

Diabetic Macular Edema
NCT03452722

Completed

Neuroinflammatory Response in Patients With ICH and IVH Treated With rtPA

Brain Injuries | Intraventricular Hemorrhage | Hypertensive Intracerebral Hemorrhage
NCT02788877

Unknown

Treat-and-extend Regimen of Aflibercept in Diabetic Macular Edema (VIBIM Study) (VIBIM)

Macular Edema, Diabetic
NCT03793400

Completed

Long-term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis With Active Choroidal Neovascularization Managed With Anti-vascular Endothelial Growth Factor

Choroidal Neovascularization | Punctate Inner Choroidopathy
NCT02928419

Terminated

Efficacy of Eltrombopag Plus Lenalidomide Combination Therapy in Patients With IPSS Low and Intermediate-risk Myelodysplastic Syndrome With Isolated del5q

Myelodysplastic Syndromes
NCT01625936

Completed

CRLX101 Plus Bevacizumab in Advanced RCC

Renal Cell Carcinoma
NCT00535873

Completed

Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) Age 65 and Older

Leukemia | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLL
NCT03240549

Unknown

Effectiveness and Safety of Adding Bevacizumab to First Line Chemotherapy in Lung Cancer Patients With Stable Disease

Non-small Cell Lung Cancer Metastatic
NCT01343901

Completed

An Observational Study on Bevacizumab (Avastin) as First-Line Treatment in Colorectal Cancer Participants With Potentially Resectable Liver Metastases (PICASSO)

Colorectal Cancer
NCT03115762

Unknown

Pharmacokinetics and Safety Study of ASKB1202 in Chinese Healthy Subjects

Healthy
NCT02059772

Unknown

Combination of Standard Lucentis Therapy With Micropulse Diode Laser for the Treatment of Diabetic Macular Edema (ReCaLL)

Diabetic Macular Edema
NCT00875147

Completed

Impact of Pre-operative Bevacizumab on Complications After Resection of Colorectal Liver Metastases

Colorectal Liver Metastases
NCT02864472

Unknown

Comparison of PDT Combination With Ranibizumab vs. Ranibizumab Monotherapy in Persistent PCV With Initial Loading Dose

Age-related Macular Degeneration
NCT00186745

Terminated

Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure

Venous Thrombosis | Pulmonary Embolism
NCT02587845

Unknown

Use of Transexamic Acid in Hip Replacement

Bleeding | Transfusion Related Complication
NCT02522897

Unknown

Evaluation of the "Treat-and-extend" Scheme in Patients With Retinal Vein Occlusion (RVO) With and Without LASER Treatment of Ischaemic Retinal Areas (PEARL)

Central Retinal Vein Occlusion With Macular Edema
NCT00700102

Completed

A Study of Avastin (Bevacizumab) Plus Crossover Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal Cancer.

Colorectal Cancer
NCT00601926

Terminated

Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer

Kidney Cancer
NCT00401193

Completed

Efficacy and Safety of XP12B in Women With Menorrhagia

Menorrhagia | Heavy Menstrual Bleeding
NCT00885508

Unknown

A Study of the Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5q (GFM-Chimio-Rev)

Acute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome
NCT00879957

Withdrawn

Heparin Versus no Heparin on Duration of Peripherally Inserted Central Catheter (PICC) Patency in Neonates

Thrombosis | Anticoagulants | Infant, Premature
NCT01368757

Unknown

Lenalidomide in Patients With Chronic Myelomonocytic Leukemia

Chronic Myelomonocytic Leukemia
NCT00967148

Completed

Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon Cancer (PERI-OP)

Cancer | Deep Vein Thrombosis | Pulmonary Embolism
NCT00499590

Terminated

Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (COBALT)

Macular Degeneration
NCT00546897

Completed

Lenalidomide in Older Patients With Acute Myeloid Leukemia Without Chromosome 5q Abnormalities

Leukemia, Myeloid, Acute
NCT00271609

Completed

Bevacizumab for Recurrent Malignant Glioma

Recurrent High-Grade Gliomas | Malignant Gliomas
NCT01085734

Completed

Single Site, Masked, Randomized, Controlled Study to Assess Efficacy of Osurdex as Adjunct to Avastin Compared With Avastin Alone in the Treatment of Patients With Macular Edema Due to Central or Branch Retinal Vein Occlusion

Retinal Vein Occlusions
NCT00096967

Completed

A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study

Breast Cancer | Colorectal Cancer | Metastases
NCT00360672

Completed

Revlimid in Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome

Myelodysplastic Syndrome | Acute Myelogenous Leukemia
NCT00056823

Completed

Intravitreal Injections of rhuFab V2 in Combination With Visudyne in Subjects With Age Related Macular Degeneration (AMD)

Age-Related Maculopathy
NCT00109070

Completed

A Study to Evaluate Avastin in Combination With Standard Chemotherapy to Treat Colorectal Cancer

Colorectal Cancer

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations